Oncotarget · 2016 · 39 citations · 26 references
MedicineSurgeryUrologyGenitourinary OncologySurgical OncologyUrologic OncologyBiomarkers In Genitourinary CancerBiomarkers In Urologic OncologyProstate CancerProstate SurgeryRadical ProstatectomyCancer-associated NeutrophilsClinical Survival RatesKaplan-meier Survival EstimatesNeutrophil-to-lymphocyte RatioOverall Survival After RecurrencePrognosis Of Prostate DiseaseProstate Cancer PrognosisSurvival Rates
// Won Sik Jang 1 , Kang Su Cho 1 , Myung Soo Kim 1 , Cheol Yong Yoon 1 , Dong Hyuk Kang 1 , Yong Jin Kang 1 , Won Sik Jeong 1 , Won Sik Ham 1 , Young Deuk Choi 1 1 Department of Urology, Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea Correspondence to: Young Deuk Choi, email: youngd74@yuhs.ac Won Sik Jang, email: sindakjang@yuhs.ac Keywords: neutrophil-to-lymphocyte ratio, prostate cancer, radical prostatectomy, biochemical recurrence, survival Received: September 06, 2016 Accepted: December 15, 2016 Published: December 29, 2016 ABSTRACT Background: The pretreatment neutrophil-to-lymphocyte ratio has prognostic value after radical prostatectomy for treating localized prostate cancer. However, the use of postoperative neutrophil-to-lymphocyte ratio has not been evaluated in this population. We investigated the prognostic significance of early postoperative neutrophil-to-lymphocyte ratio after radical prostatectomy for prostate cancer. Methods: We retrospectively reviewed clinical data from 2,302 patients with localized prostate cancer who underwent radical prostatectomy at our institution between years 2000 and 2010. Only patients with pre- and postoperative complete blood counts with differential results were included. Patients who received neoadjuvant or postoperative adjuvant treatment and those without adequate medical records were excluded. Kaplan-Meier analyses were performed to analyze biochemical recurrence-free survival and overall survival rates. Univariate and multivariate Cox regression models were used for each endpoint. Results: Kaplan-Meier curves showed that high postoperative neutrophil-to-lymphocyte ratio (>3.5) was significantly associated with decreased biochemical recurrence-free survival ( p = 0.009) and overall survival ( p = 0.010). In the univariate and multivariate Cox regression analyses, high postoperative neutrophil-to-lymphocyte ratio was a significant predictor of biochemical recurrence (hazard ratio 1.270, p = 0.008) and overall survival (hazard ratio 1.437, p = 0.033). Conclusions: Our results demonstrate that postoperative neutrophil-to-lymphocyte ratio is an independent factor for biochemical recurrence and overall survival in patients who underwent radical prostatectomy for prostate cancer. These findings suggest that neutrophil-to-lymphocyte ratio can be a potentially valuable tool for stratifying high-risk patients and facilitating choices of postoperative therapy in patients with prostate cancer.
26